Table 1.
Quantification of neurons that coexpress NADPHd activity and leptin-induced pSTAT3-ir in hypothalamic nuclei
| Nuclei | Atlas levels | NADPHd cells | pSTAT3-ir cells | Dual-labeled cells | NADPHd cells expressing pSTAT3-ir (%) | pSTAT3-ir cells expressing NADPHd (%) | 
|---|---|---|---|---|---|---|
| MPAl | 18 | 62.8 ± 11.3 | 43.0 ± 6.3 | 19.4 ± 3.0 | 34.0% ± 6.9 | 46.0% ± 5.5 | 
| Arc | 31 | 31.7 ± 1.9 | 129.3 ± 13.3 | 9.3 ± 2.0 | 29.5% ± 5.9 | 7.2% ± 1.3 | 
| DMHv | 31 | 142.3 ± 23.5 | 127.5 ± 10.4 | 46.7 ± 5.5 | 35.0% ± 5.1 | 36.2% ± 2.0 | 
| PH | 33 | 80.7 ± 8.2 | 39.7 ± 5.0 | 30.4 ± 3.5 | 39.6% ± 4.7 | 78.8% ± 5.4 | 
| PMV | 33 | 209.4 ± 8.0 | 186.8 ± 4.9 | 136.2 ± 4.4 | 65.2% ± 1.6 | 73.0% ± 2.4 | 
We quantified the number of cells that express NADPHd activity, pSTAT3-ir, and both (dual labeled cells). Percentage of NADPHd cells that coexpress pSTAT3-ir and the percentage of pSTAT3-ir cells that coexpress NADPHd activity (n = 3–7 cases/nucleus) was estimated. Data are expressed as mean ± sem. The atlas level designation corresponds to those described by Paxinos and Franklin (47).